Amit Sachdev is VP at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 43 open-market trades across 1 company since 2007, most recently 2026-07-21.
CIK 0001406338
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2007, against 42 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRTX | 66,512 | $33.2M |
| EIGR | 16,000 | $28K |
| Total | $33.3M |
Shares reported on the most recent Form 4, priced at the 2026-07-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL · 10b5-1 | 2026-02-25 | 2026-02-26 | $486.35 | $898K | +3.9% | -7.7% | -9.0% |
| VRTX | SELL | 2026-02-19 | 2026-02-23 | $468.83 | $27.5M | -3.8% | -5.1% | -9.0% |
| VRTX | SELL · 10b5-1 | 2024-05-15 | 2024-05-17 | $430.93 | $14K | -0.4% | +6.5% | +6.1% |
| VRTX | SELL · 10b5-1 | 2024-02-26 | 2024-02-27 | $425.70 | $2.6M | -3.7% | -2.7% | +4.0% |
| VRTX | SELL · 10b5-1 | 2024-02-21 | 2024-02-23 | $421.77 | $2.7M | -3.3% | -2.3% | +5.9% |
| VRTX | SELL · 10b5-1 | 2024-02-20 | 2024-02-21 | $420.79 | $3.6M | +1.0% | -1.0% | +5.3% |
| VRTX | SELL · 10b5-1 | 2024-02-12 | 2024-02-13 | $420.24 | $2.7M | +3.6% | -2.3% | +2.8% |
| VRTX | SELL · 10b5-1 | 2023-11-15 | 2023-11-17 | $369.92 | $13K | +1.4% | +15.7% | +21.9% |
| VRTX | SELL · 10b5-1 | 2023-08-10 | 2023-08-14 | $350.00 | $3.5M | -0.7% | -0.7% | +8.5% |
| VRTX | SELL · 10b5-1 | 2021-11-15 | 2021-11-16 | $187.19 | $10K | +0.8% | +12.7% | +22.6% |
| VRTX | SELL · 10b5-1 | 2021-05-17 | 2021-05-19 | $216.35 | $10K | -2.0% | -12.2% | -7.2% |
| VRTX | SELL | 2021-04-27 | 2021-04-29 | $216.02 | $1.6M | -0.2% | -1.7% | -5.2% |
| VRTX | SELL | 2021-02-25 | 2021-02-26 | $213.33 | $1.2M | +0.8% | +1.9% | -2.5% |
| VRTX | SELL | 2021-02-18 | 2021-02-19 | $211.83 | $2.0M | +0.8% | +5.9% | +4.8% |
| VRTX | SELL | 2021-02-11 | 2021-02-16 | $210.50 | $1.8M | +1.4% | +1.8% | +3.2% |
| VRTX | SELL · 10b5-1 | 2020-11-16 | 2020-11-18 | $223.53 | $9K | +6.4% | +9.4% | -2.8% |
| VRTX | SELL | 2020-08-03 | 2020-08-05 | $278.47 | $942K | +1.7% | -1.0% | -21.6% |
| VRTX | SELL · 10b5-1 | 2020-05-15 | 2020-05-19 | $284.41 | $16K | +0.6% | -2.0% | -3.9% |
| VRTX | SELL | 2020-05-11 | 2020-05-13 | $282.77 | $5.5M | -4.0% | -3.2% | -5.7% |
| VRTX | SELL | 2020-05-06 | 2020-05-08 | $275.28 | $368K | +4.9% | -2.4% | +0.7% |
| VRTX | SELL | 2020-05-04 | 2020-05-06 | $264.05 | $29.9M | +4.2% | -2.6% | +1.1% |
| VRTX | SELL | 2020-02-25 | 2020-02-26 | $234.05 | $1.1M | -3.9% | -4.9% | +16.6% |
| VRTX | SELL | 2020-02-18 | 2020-02-19 | $243.51 | $1.2M | -6.1% | -16.7% | +14.1% |
| VRTX | SELL | 2020-02-11 | 2020-02-12 | $246.14 | $6.1M | -4.7% | -8.5% | +14.5% |
| VRTX | SELL | 2020-02-03 | 2020-02-05 | $231.16 | $1.7M | +1.6% | -3.6% | +12.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.